George Kollias, PhD

Professor of Physiology, Medical School, National and Kapodistrian, University of Athens, Research Professor, Biomedical Sciences Research Center “Alexander Fleming”, Member of the Academy of Athens.

George Kollias’s laboratory has pioneered genetic approaches to understand the function of cytokine signaling in animal models of human diseases and contributed knowledge on molecular and cellular mechanisms underlying chronic inflammation. Ηis team’s groundbreaking preclinical studies on the role of TNF in joint pathology paved the way for the development of anti-TNF therapies for Rheumatoid Arthritis. More recently, his lab elucidated the prominent involvement of fibroblasts in chronic inflammatory diseases, immunity, and cancer. The disease models and genetic tools created in his lab aid research globally in academic and industrial settings.

George Kollias is a Professor of Physiology (Medical School, UoA), Research Professor at the BSRC “Alexander Fleming“, and Member of the Academy of Athens and the European Molecular Biology Organization (EMBO). He served as President and Director of the BSRC “Alexander Fleming” (2002-2010 & 2016-2020) and Director of the Department of Physiology, Medical School, UoA (2020-2023). He is Founder and President of Biomedcode Hellas SA. Since 2016, he has founded and directs the International Graduate Program in “Molecular Biomedicine“. He has led efforts for the development of research infrastructures at the national and European level. His laboratory secured funding from several prestigious sources including two advanced grants from the European Research Council (ERC) in 2014 and 2022.